← Leaderboards

Andrew Stephen Bomback

Univ Of North Carolina Chapel Hill

Google Scholar ↗PubMed ↗ORCID ↗

$3,235,628

Attributed

$9,278,909

Total exposure

5

Grants

1

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.6M · FY2014–25

$2M$1.5M$1M$500K$0

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$9,278,909 · 5

By mechanism

R01$4,776,139 · 2

U01$2,855,606 · 1

UH3$900,000 · 1

UG3$747,164 · 1

Top collaborators

Most similar at Univ Of North Carolina Chapel Hill

Same institution · by research overlap

Others in their field

Top investigators on “Cohort”

David R. Weir · University Of Michigan At Ann Arbor$406,814,098
George R Seage · Abt Associates, Inc.$297,656,361
Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$242,146,554
Glenda E Gray · Wits Health Consortium (Pty), Ltd$227,738,417
Lawrence Corey · Fred Hutchinson Cancer Center$227,738,417
James Dennis Neaton · Northwestern University$203,539,316

Research focus

CohortBiopsyMembranous GlomerulonephritisResourcesKidneyRenal Glomerular DiseaseBiological MarkersKidney DiseasesClinical DataEnrollmentGeneticAffectBiobankRecruitFuturePathologyStandardizationFollow-UpDiagnosisProtocols DocumentationMorbidity - Disease RatePrecision MedicineCollectionAdult

Grant awards (24)

The Columbia PCC for CureGN: the Cure Glomerulonephropathy network$696,310

U01 · FY2025 · DK · contact PI

The Impact of Diabetes on Patients with Glomerular Disease: CureGN-Diabetes$598,715

R01 · FY2025 · DK

The Columbia PCC for CureGN: the Cure Glomerulonephropathy network$161,786

U01 · FY2025 · DK · contact PI

The Columbia PCC for CureGN: the Cure Glomerulonephropathy network$86,485

U01 · FY2025 · DK · contact PI

The Columbia PCC for CureGN: the Cure Glomerulonephropathy network$42,204

U01 · FY2025 · DK · contact PI

The Impact of Diabetes on Patients with Glomerular Disease: CureGN-Diabetes$12,807

R01 · FY2025 · DK

The Columbia PCC for CureGN: the Cure Glomerulonephropathy network$924,999

U01 · FY2024 · DK · contact PI

The Impact of Diabetes on Patients with Glomerular Disease: CureGN-Diabetes$605,141

R01 · FY2024 · DK

The Columbia PCC for CureGN: the Cure Glomerulonephropathy network$943,822

U01 · FY2023 · DK

The Impact of Diabetes on Patients with Glomerular Disease: CureGN-Diabetes$651,102

R01 · FY2022 · DK

The Impact of Diabetes on Patients with Glomerular Disease: CureGN-Diabetes$745,696

R01 · FY2021 · DK

Kidney Precision Medicine Program (KPMP): Columbia AKI Recruitment Site$300,000

UH3 · FY2021 · DK

Kidney Precision Medicine Program (KPMP): Columbia AKI Recruitment Site$300,000

UH3 · FY2020 · DK

Kidney Precision Medicine Program (KPMP): Columbia AKI Recruitment Site$300,000

UH3 · FY2019 · DK

Ancestry, Genetic Risk and Health Disparities in Immune-Mediated Nephritis$400,000

R01 · FY2018 · MD

Kidney Precision Medicine Program (KPMP): Columbia AKI Recruitment Site$333,334

UG3 · FY2018 · DK

Ancestry, Genetic Risk and Health Disparities in Immune-Mediated Nephritis$15,334

R01 · FY2018 · MD

Kidney Precision Medicine Program (KPMP): Columbia AKI Recruitment Site$413,830

UG3 · FY2017 · DK

Ancestry, Genetic Risk and Health Disparities in Immune-Mediated Nephritis$400,000

R01 · FY2017 · MD

Ancestry, Genetic Risk and Health Disparities in Immune-Mediated Nephritis$92,006

R01 · FY2017 · MD

Ancestry, Genetic Risk and Health Disparities in Immune-Mediated Nephritis$400,000

R01 · FY2016 · MD

Ancestry, Genetic Risk and Health Disparities in Immune-Mediated Nephritis$61,338

R01 · FY2016 · MD

Ancestry, Genetic Risk and Health Disparities in Immune-Mediated Nephritis$400,000

R01 · FY2015 · MD

Ancestry, Genetic Risk and Health Disparities in Immune-Mediated Nephritis$394,000

R01 · FY2014 · MD